Richard Baker secures UK-Scotland co-operation on prostate-cancer therapy

The government says it is willing to share evidence from a £2.8 million expansion of focal therapy in English specialist centres.

Labour MP Richard Baker has secured a commitment that the UK government will work with Scotland and share evidence from the expansion of focal therapy for prostate cancer in England.

Richard Baker MP. Photo: UK Parliament (official portrait).
Richard Baker MP. Photo: UK Parliament (official portrait).

The Glenrothes and Mid Fife MP argued that many men diagnosed with localised prostate cancer could benefit from treatment that targets tumours while reducing damage to surrounding tissue.

He told the Commons that focal therapy can produce substantially fewer harmful side effects than more invasive treatments, while noting that access in Scotland remains limited.

Health Secretary Yvette Cooper said the government was investing £2.8 million to expand focal therapy at specialist centres in England.

Cooper said the National Institute for Health and Care Excellence would look at the progress being made, and that the government would be keen to work with the Scottish Government so it could see the same results.

Health policy is devolved, so the commitment does not itself expand provision in Scotland. It could, however, give Scottish decision-makers additional clinical and implementation evidence.

Showing 1 reaction

Please check your e-mail for a link to activate your account.
  • published this page in News 2026-10-20 20:00:45 +0100

Share this article

Richard Baker secures UK-Scotland co-operation on prostate-cancer therapy

Richard Baker secures UK-Scotland co-operation on prostate-cancer therapy